Second thoughts on psychedelic drugs

Endeavour

Volumn 22, Issue 1, 1998, Pages 21-23

  Novak, Steven J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031943417     PISSN: 01609327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0160-9327(98)01096-5     Document Type: Article

References (24)

1. 1 Elkes, J. (1964) in Discoveries in Biological Psychiatry (Ayd, F.J. and Blackwell, B., eds), p. 64, J.B. Lippincott
2. 2 For a bibliography of this literature, Hoffer, A., Osmond, H., Weckowicz, T. (1967) The Hallucinogens, Academic Press
3. 3 Caldwell, W.V. (1967) LSD Psychotherapy: An Exploration of Psychedelic and Psycholytic Therapy, Grove Press
4. 4 Leiby, R. (1997) Esquire 98 (September 1997), 98-103
5. 5 Congressional testimony of James Goddard, Director of the United States Food and Drug Administration, in U.S. Senate Subcommittee on Executive Reorganization, 24, 25, 26, May 1966, Organization and Coordination of Federal Drug Research and Regulators Programs: LSD, p. 64, Government Printing Office, Washington DC, 1966
6. 6 Cohen, S. (1953) Am. J. Med. 15, 813-828
7. 7 Sidney Cohen, LSD Report, 13 October 1955, in Leonard Asher papers, privately held; the bulk of the report was reprinted anonymously in Cohen, S. (1964) The Beyond Within: The LSD Story, pp. 106-111, Athenaeum, New York
8. 8 Cohen, S., Fichman, L. and Eisner, B.G. (1958) Am. J. Psychiat. 115, 30-35
9. 9 Sidney Cohen, unpublished, undated draft of an essay for a commemorative volume planned after Heard's death, quoted in Novak, S.J. (1997) Isis 88, 87-110
10. 10 Cohen, S.J. (1960) J. Nervous Mental Dis. 130, 30-39
11. 11 Hyams, J. (1959) 20 April 1959, p. 16; 21 April 1959, p. 22
12. 11 Hyams, J. (1959) 20 April 1959, p. 16; 21 April 1959, p. 22
13. 12 Sidney Cohen to William Harlan Hale, 18 January 1963, quoted in Ref. 9
14. 13 Deery, J. (1996) Aldous Huxley and the Mysticism of Science, St Martin's Press
15. 14 Sidney Cohen to Robert Lynch, 4 September 1959, quoted in Ref. 9
16. 15 Sidney Cohen to William H. Stevens, 22 June 1961 and 21 December 1961, quoted in Ref. 9
17. 16 Cohen, S. and Ditman, K.S.J. (1962) J. Am. Med. Ass. 181, 161-162, 14 July; Cohen and Ditman elaborated their analysis in Am. Med. Ass. Arch. Gen. Psychiat. 8, 475-480 (1963)
18. 16 Cohen, S. and Ditman, K.S.J. (1962) J. Am. Med. Ass. 181, 161-162, 14 July; Cohen and Ditman elaborated their analysis in Am. Med. Ass. Arch. Gen. Psychiat. 8, 475-480 (1963)
19. 17 Grinker, R.R., Sr (1963) Am. Med. Ass. Arch. Gen. Psychiat. 8, 425
20. 18 Cohen, S.J. (1985) Psychoactive Drugs 17, 291-296
21. 19 McCann, U.D., Lowe, K.A. and Ricaurte, G.A. (1997) Neuroscientist 3, 405
22. 20 Cohen, S. (1968) Am. J. Psychiat. 125, 149-150
23. 21 Cohen's congressional testimony in Organization and Coordination of Federal Drug Research and Regulatory Programs: LSD, p. 157, 1966
24. 22 Cohen, S.J. (1984) Substance Abuse Treatment 1, 155